Sir: Serotonin reuptake inhibitors (SRIs) and venlafaxine continue to play a prominent role in the treatment of depression. Utilization of these agents, however, has been complicated by the now well-described serotonin discontinuation syndrome.
Save
Cite
Advertisement
GAM ID: sidebar-top